Internal Medicine · Los Angeles, CA
NPI
1760495741
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5901 W Olympic Blvd, Ste 401
Los Angeles, CA, 90036
Phone (323) 954-1073
Medicare paid, 2023
$57K
2,055 services
Medicare patients, 2023
121
Average age 69
Drug cost, 2024
$4.7M
6,186 prescriptions
Company payments, 2025
$268
From 9 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Phillip A Musikanth was code 80061 (clinical chemistry), 126 times for 94 patients. In total Phillip A Musikanth billed 2,055 services in 58 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80061 Clinical Chemistry | Office | 126 | 94 | $13.12 | $1,653 |
| 99215 Office E&M - Established | Office | 125 | 92 | $126.42 | $16K |
| 36415 Venipuncture Blood Collection | Office | 123 | 88 | $8.40 | $1,033 |
| 80048 Clinical Chemistry | Office | 112 | 83 | $8.29 | $928 |
| 80076 Clinical Chemistry | Office | 110 | 82 | $8.01 | $881 |
| 87536 Infectious Agent Detection by DNA/RNA | Office | 100 | 71 | $83.40 | $8,340 |
| 83735 Clinical Chemistry | Office | 93 | 75 | $6.57 | $611 |
| 84100 Clinical Chemistry | Office | 89 | 67 | $4.65 | $414 |
| 84402 Clinical Chemistry | Office | 75 | 60 | $24.96 | $1,872 |
| 84403 Clinical Chemistry | Office | 75 | 60 | $25.29 | $1,897 |
| 83036 Blood Count | Office | 65 | 58 | $9.52 | $619 |
| 82306 Clinical Chemistry | Office | 61 | 57 | $29.01 | $1,770 |
| 82607 Clinical Chemistry | Office | 60 | 56 | $14.78 | $887 |
| 82746 Clinical Chemistry | Office | 58 | 56 | $14.41 | $836 |
| 99214 Office E&M - Established | Office | 57 | 43 | $92.95 | $5,298 |
By year: 2022 $126K for 3,346 services; 2023 $57K for 2,055 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 126 | 94 | $13.12 | $1,653 |
| 36415 Venipuncture Blood Collection | 123 | 88 | $8.40 | $1,033 |
| 80048 Clinical Chemistry | 112 | 83 | $8.29 | $928 |
| 80076 Clinical Chemistry | 110 | 82 | $8.01 | $881 |
| 87536 Infectious Agent Detection by DNA/RNA | 100 | 71 | $83.40 | $8,340 |
| 83735 Clinical Chemistry | 93 | 75 | $6.57 | $611 |
| 84100 Clinical Chemistry | 89 | 67 | $4.65 | $414 |
| 84402 Clinical Chemistry | 75 | 60 | $24.96 | $1,872 |
| 84403 Clinical Chemistry | 75 | 60 | $25.29 | $1,897 |
| 83036 Blood Count | 65 | 58 | $9.52 | $619 |
Medicare prescription drug claims, 2024
In 2024, the drug Phillip A Musikanth prescribed most often to Medicare patients was Atorvastatin Calcium, with 279 prescriptions and refills. In total Phillip A Musikanth wrote 6,186 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 279 | 371 | 39 | $1,386 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 201 | 205 | 21 | $782K |
| Lisinopril Generic | 194 | 258 | 26 | $776 |
| Juluca Dolutegravir/Rilpivirine | 163 | 163 | 16 | $563K |
| Tamsulosin Hcl Generic | 151 | 183 | 27 | $1,170 |
| Bupropion Xl Bupropion Hcl | 144 | 183 | 19 | $2,015 |
| Descovy Emtricitabine/Tenofov Alafenam | 142 | 142 | 15 | $316K |
| Losartan Potassium Generic | 132 | 225 | 26 | $771 |
| Acyclovir Generic | 132 | 140 | 18 | $1,209 |
| Amlodipine Besylate Generic | 122 | 210 | 23 | $520 |
| Testosterone Generic | 117 | 120 | 20 | $14K |
| Tivicay Dolutegravir Sodium | 116 | 116 | 13 | $315K |
| Isentress Raltegravir Potassium | 109 | 109 | 12 | $216K |
| Gabapentin Generic | 108 | 108 | 14 | $1,119 |
| Famotidine Generic | 107 | 117 | 12 | $487 |
Brand drugs: 1,419 claims; generic drugs: 4,744 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Phillip A Musikanth $268 ($268 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $53.99.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 2 | $53.99 |
| Abbvie Inc. ABBV | 1 | $34.1 |
| Merck Sharp & Dohme LLC MRK | 1 | $31.94 |
| Gilead Sciences, Inc. GILD | 1 | $29.47 |
| Axsome Therapeutics, Inc. AXSM | 1 | $27.83 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $24.75 |
| Bausch Health US, LLC BHC | 1 | $22.49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $22.42 |
| GlaxoSmithKline, LLC. GSK | 1 | $21.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.